Negative Pressure Wound Therapy Systems Market Summary
- The Negative Pressure Wound Therapy Systems market size is estimated at USD 3.70 billion in 2025 and is projected to reach USD 5.79 billion by 2034. Growth is anchored in the rising burden of chronic and surgical wounds, the escalating prevalence of diabetes, and the rapid expansion of single-use and closed-incision negative pressure wound therapy.
- The global Negative Pressure Wound Therapy Systems market is growing at a CAGR of 5.1% during the forecast period from 2026 to 2034.
- By product type, the conventional NPWT devices segment dominated the Negative Pressure Wound Therapy Systems market with a 64% share in 2025.
- By wound type, the diabetic ulcers segment dominated the Negative Pressure Wound Therapy Systems market with a share of 34% in 2025.
- By end-user, the hospitals segment dominated the Negative Pressure Wound Therapy Systems market with a share of 58% in 2025.
- North America dominated the global Negative Pressure Wound Therapy Systems market revenue with a share of 42% in 2025, representing the highest regional market share globally.
Negative pressure wound therapy (NPWT) is an advanced wound care modality that applies controlled sub-atmospheric pressure to a wound through a sealed dressing connected to a vacuum pump, promoting healing by removing exudate and infectious material, reducing edema, increasing blood flow, and drawing wound edges together. A complete NPWT system comprises a therapy unit, a specialized foam or gauze filler and sealing drape, and a canister or absorbent dressing to collect fluid. The category spans conventional, powered NPWT devices used for complex and larger wounds, often with instillation capability, and single-use, disposable, and portable NPWT devices designed for smaller wounds, closed surgical incisions, and ambulatory or home use. NPWT is used across chronic wounds such as diabetic, pressure, and venous ulcers, as well as surgical, traumatic, and burn wounds, in hospitals, specialty and ambulatory clinics, and home settings. Over the past decade, the field has advanced from bulky hospital units toward portable, single-use, closed-incision, and instillation-capable systems, establishing NPWT as a central technology in the management of complex and hard-to-heal wounds worldwide.
Negative Pressure Wound Therapy Systems Market Key Growth Drivers
- The rising global burden of chronic wounds, including diabetic, pressure, and venous ulcers, is a primary driver of NPWT adoption.
- The escalating prevalence of diabetes is a major catalyst, with the International Diabetes Federation estimating that 589 million adults were living with diabetes in 2024, driving a high incidence of diabetic foot ulcers.
- The rapid expansion of single-use and closed-incision NPWT for surgical site infection prevention is broadening clinical use.
- The growing volume of surgical procedures and rising surgical site infection prevention efforts are increasing demand for NPWT.
- The shift of NPWT to outpatient and home settings, enabled by portable and single-use devices, is broadening access.
- Clinical evidence and guidelines supporting NPWT for complex wounds and closed surgical incisions are reinforcing adoption.
- The convergence of rising chronic and surgical wound burden, diabetes prevalence, and single-use and closed-incision innovation is expected to sustain steady growth in the global Negative Pressure Wound Therapy Systems market through 2034.
Key Companies in Negative Pressure Wound Therapy Systems Market
The competitive landscape is led by the following active manufacturers and solution providers:
- Solventum Corporation
- Smith & Nephew plc
- Convatec Group PLC
- Cardinal Health, Inc.
- Molnlycke Health Care AB
- Medela AG
- DeRoyal Industries, Inc.
- Talley Group Ltd
- Paul Hartmann AG
- Genadyne Biotechnologies, Inc., and others
For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.
Negative Pressure Wound Therapy Systems Market Size
The following snapshot summarizes the principal report metrics for the Negative Pressure Wound Therapy Systems market.
|
Report Metrics |
Details |
|
2025 Market Size |
USD 3.70 billion |
|
2034 Projected Market Size |
USD 5.79 billion |
|
Growth Rate (2026-2034) |
5.1% CAGR |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia-Pacific |
|
Market Structure |
Consolidated |
All market values are expressed in USD and represent DelveInsight estimates synthesized from primary and secondary research.
Factors Contributing to the Growth of the Negative Pressure Wound Therapy Systems Market
Negative Pressure Wound Therapy Systems Market Drivers
- Rising Global Burden of Chronic Wounds: The escalating burden of chronic and hard-to-heal wounds is the foundational driver of negative pressure wound therapy demand. Chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, affect a large and growing population, particularly older adults and those with diabetes, obesity, and vascular disease, and they are prone to prolonged healing, infection, and complications. NPWT is a well-established, evidence-supported modality for these complex wounds, promoting healing by removing exudate, reducing edema, and stimulating granulation tissue formation. The high recurrence and slow healing of chronic wounds generate sustained, repeat use of NPWT devices and consumables. Health systems increasingly recognize the clinical and economic burden of unhealed wounds and adopt NPWT to accelerate healing and reduce complications and length of stay. As the population ages and the prevalence of underlying conditions rises, the pool of patients with chronic wounds continues to expand, creating durable and growing demand for NPWT that reinforces sustained market growth throughout the forecast period.
- Escalating Prevalence of Diabetes and Diabetic Foot Ulcers: The rising global prevalence of diabetes is a powerful and specific catalyst for NPWT. The International Diabetes Federation estimated that 589 million adults were living with diabetes in 2024, and the number continues to rise with aging, urbanization, and lifestyle changes. Diabetic foot ulcers are among the most serious complications of diabetes, with a substantial lifetime risk among people with diabetes, and they are complex, slow to heal, prone to infection, and a leading cause of lower-limb amputation. NPWT is widely used in the management of diabetic foot ulcers to promote healing and reduce the risk of amputation, and the large and growing diabetic population directly expands the incidence of these ulcers and the demand for NPWT. As diabetes prevalence continues to climb worldwide and efforts to prevent amputation intensify, demand for NPWT in diabetic foot ulcer management is expected to be a leading contributor to market growth across the forecast period.
- Expansion of Single-Use and Closed-Incision NPWT: The rapid growth of single-use and closed-incision NPWT is a major driver of market expansion. Single-use, disposable, and portable NPWT devices, exemplified by Smith & Nephew's PICO and Solventum's Prevena, have exten Dry Eye Disease negative pressure therapy from complex open wounds to smaller wounds and, importantly, to closed surgical incisions for the prevention of surgical site infection and complications in high-risk patients. Systematic reviews and meta-analyses have demonstrated that single-use NPWT reduces surgical site infections in closed incisions compared with conventional dressings, strengthening the clinical and economic case for prophylactic use. These devices are lightweight, portable, and suitable for ambulatory and home use, broadening the settings and patient populations served. The prophylactic closed-incision application opens a large new addressable market beyond traditional wound healing. As clinical evidence accumulates and adoption of single-use and closed-incision NPWT grows, this segment is expected to be a leading driver of market growth across the forecast period.
- Growing Surgical Volumes and Surgical Site Infection Prevention: The rising volume of surgical procedures and the intensifying focus on preventing surgical site infections are expanding NPWT demand. Surgical site infections are a common and costly complication, and closed-incision NPWT is increasingly used prophylactically in high-risk surgical patients to reduce infection, dehiscence, and other complications. As surgical volumes rise with aging populations and expanding access to care, and as the prevention of surgical site infections becomes a clinical and economic priority tied to quality metrics and reimbursement, the prophylactic use of NPWT grows. Manufacturers offer Dry Eye Diseaseicated closed-incision NPWT systems designed for incision management, and clinical guidelines and evidence increasingly support their use in appropriate patients. The financial penalties associated with hospital-acquired complications further encourage adoption. This growth in surgical site management is expected to be an important contributor to NPWT demand across the forecast period, complementing traditional wound-healing applications.
- Shift to Outpatient and Home-Based NPWT: The migration of NPWT from inpatient to outpatient and home settings is broadening access and expanding the market. Advances in portable and single-use NPWT devices enable therapy to be delivered outside the hospital, allowing patients to continue treatment at home or in ambulatory settings, reducing hospital stays and costs and improving convenience. Single-use devices are designed for ease of use and mobility, supporting the large population of chronic wound patients who require ongoing, long-term therapy. The shift aligns with health system efforts to reduce length of stay and readmissions, and reimbursement models increasingly support home NPWT. Home health providers and specialty clinics increasingly deliver NPWT, expanding the settings in which it is used. As portable technologies, home health infrastructure, and supportive reimbursement continue to develop, the shift toward outpatient and home-based NPWT is enlarging the settings and patient populations served, contributing meaningfully to market growth across the forecast period.
- Clinical Evidence, Guidelines, and Technological Advancement: Growing clinical evidence, guideline support, and continuous innovation are reinforcing NPWT adoption. A substantial body of evidence supports NPWT for complex wound healing and, increasingly, for closed-incision surgical site infection prevention, and clinical guidelines and wound care standards incorporate NPWT into treatment pathways. Technological advancement continues to enhance the modality, including instillation NPWT that combines negative pressure with topical wound irrigation for infected and complex wounds, exemplified by systems such as V.A.C. VeraFlo, as well as quieter, smaller, and connected devices with improved canister and dressing designs. Single-use and disposable innovation has expan Dry Eye Disease the addressable market, and improvements in portability and ease of use support home care. These advances improve outcomes, expand indications, and differentiate competing systems. As evidence accumulates, guidelines evolve, and technology advances toward instillation, connectivity, and disposability, ongoing innovation is expected to be a significant driver of NPWT adoption and competitive differentiation across the forecast period.
Negative Pressure Wound Therapy Systems Market Restraints
Despite strong momentum, the Negative Pressure Wound Therapy Systems market faces material constraints. The high cost of conventional NPWT devices, along with the recurring expense of proprietary foam, dressings, and canisters, places pressure on healthcare budgets and can limit adoption relative to advanced dressings and conventional care. Reimbursement complexity and scrutiny are significant, as coverage and payment for NPWT, particularly durable medical equipment for home use, are subject to documentation requirements, prior authorization, and competitive bidding in some systems, creating uncertainty for providers and manufacturers. Device-related complications, including bleeding, infection, pain, and tissue adherence, require careful patient selection and monitoring, and NPWT is contraindicated in certain wounds. The effective use of NPWT requires trained clinicians and adherence to protocols, and a shortage of specialized wound care personnel can constrain optimal use. Competition from advanced dressings and other wound care modalities limits penetration in some applications, and the higher cost of NPWT must be justified by improved outcomes. Regulatory requirements under frameworks such as the European Medical Device Regulation raise evidence and compliance burdens. Product recalls and safety actions can disrupt supply and confidence. Finally, uneven access to NPWT and constrained budgets in emerging markets restrain the pace of adoption across parts of the sector.
Negative Pressure Wound Therapy Systems Market Segment Analysis
The Negative Pressure Wound Therapy Systems Market is segmented by product type (conventional npwt devices, single-use npwt devices), wound type (diabetic ulcers, pressure ulcers, venous leg ulcers, surgical and traumatic wounds, burns, others), end-user (hospitals, specialty and ambulatory clinics, home care settings, others), and geography (North America, Europe, Asia-Pacific, Rest of World).
By Product Type
Dominant Subsegment: Conventional NPWT Devices.
The conventional NPWT devices segment accounted for 64% of the Negative Pressure Wound Therapy Systems market in 2025. Conventional, powered NPWT devices dominate because they are the established standard for the management of complex, larger, and highly exudative wounds, including advanced chronic ulcers and open surgical and traumatic wounds, and they support extenDry Eye Disease therapy with higher fluid capacity and, in many systems, instillation capability. These devices, exemplified by Solventum's V.A.C. therapy systems including instillation-capable V.A.C. VeraFlo, are widely used in hospitals and are supported by a large installed base and extensive clinical evidence. Their capacity to manage demanding wounds, deliver adjustable and continuous or intermittent therapy, and support instillation secures their leading revenue share. Single-use NPWT devices, including Smith & Nephew's PICO, Convatec's Avelle, and closed-incision systems such as Prevena, are the fastest-growing segment, extending therapy to smaller wounds, closed surgical incisions, and ambulatory and home settings. While single-use devices are growing rapidly and expanding the addressable market, conventional devices retain leadership in 2025 on the strength of their capability, installed base, and use in complex wounds across the forecast period.
By Wound Type
Dominant Subsegment: Diabetic Ulcers.
The diabetic ulcers segment accounted for 34% of the Negative Pressure Wound Therapy Systems market in 2025. Diabetic ulcers dominate because they are among the most prevalent, complex, and costly chronic wounds, driven by the large and rapidly growing diabetic population, which the International Diabetes Federation estimated at 589 million adults in 2024. Diabetic foot ulcers are slow to heal, prone to infection, and a leading cause of lower-limb amputation, and NPWT is widely used to promote healing and reduce amputation risk in these wounds, generating substantial and repeat device and consumable use. Pressure ulcers represent a major segment driven by aging and immobility, and venous leg ulcers are a large chronic wound category tied to vascular disease. Surgical and traumatic wounds are a significant and fast-growing application, particularly with the expansion of closed-incision NPWT for surgical site infection prevention, and burns and other wounds add further demand. Nonetheless, the high prevalence, complexity, cost, and amputation-prevention focus associated with diabetic ulcers secure the segment's leadership across the forecast period, with surgical and other wound applications growing strongly alongside.
By End-User
Dominant Subsegment: Hospitals.
The hospitals segment accounted for 58% of the Negative Pressure Wound Therapy Systems market in 2025. Hospitals dominate because they manage the largest volume of complex, acute, and high-acuity wounds, including advanced chronic ulcers, open surgical and traumatic wounds, and closed surgical incisions in high-risk patients, and they possess the wound care teams, therapy devices, and infrastructure required for conventional and instillation NPWT. The initiation of NPWT, management of complex wounds, and prophylactic closed-incision therapy concentrate device use in hospitals, which are also the primary purchasers of conventional NPWT systems. Hospital wound care and infection-prevention programs further drive demand. Specialty and ambulatory clinics represent a large and growing end user, delivering outpatient wound management and increasingly using single-use NPWT, while home care settings are expanding rapidly as portable and single-use devices enable therapy to continue at home over long treatment courses. Other settings, including long-term care, add further demand. Nonetheless, hospitals retain leadership in 2025 on the strength of their wound volume, acuity, and infrastructure across the forecast period, with home and outpatient use growing as therapy shifts outside the hospital.
Negative Pressure Wound Therapy Systems Market Region Analysis
Dominant Region: North America
North America accounted for 42% of the global Negative Pressure Wound Therapy Systems market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a high burden of diabetes and chronic wounds, advanced wound care infrastructure, and early adoption of single-use and closed-incision NPWT. The United States leads on the strength of a large diabetic and aging population, a high incidence of diabetic foot and pressure ulcers, extensive hospital and specialty wound care networks, and the presence of the leading NPWT manufacturers, including Solventum, whose V.A.C. therapy franchise is the market benchmark, and Smith & Nephew. Disease burden is substantial, with a large population living with diabetes and at risk of foot ulcers and amputation, and high surgical volumes drive closed-incision NPWT use. The regulatory environment is well defined, with the Food and Drug Administration providing established pathways for NPWT devices, and reimbursement supports both inpatient and home use, though it is subject to documentation and competitive bidding. Strong adoption of single-use and closed-incision NPWT and a concentration of manufacturers reinforce demand. This combination of disease burden, infrastructure, and innovation reinforces North America's leadership in the global market.
Fastest Growing Region: Asia-Pacific
Asia-Pacific is the fastest-growing region in the Negative Pressure Wound Therapy Systems market. The region's elevated CAGR is driven by large and aging populations, a rapidly rising prevalence of diabetes, and expanding healthcare access and surgical capacity across China, Japan, India, South Korea, and Australia. The region has among the highest and fastest-growing diabetic populations in the world, driving a large and increasing incidence of diabetic foot ulcers and other chronic wounds. Growing healthcare investment, rising surgical volumes, and increasing awareness of advanced wound care and surgical site infection prevention are accelerating adoption of NPWT, including single-use devices. Both global manufacturers and regional providers are expanding their presence with conventional and single-use NPWT and cost-effective options tailored to local requirements, and improving access to wound care is broadening adoption beyond major urban centers. Government initiatives to address diabetes and its complications further support growth. The combination of large patient populations, rising diabetes burden, and expanding healthcare capacity positions Asia-Pacific as the highest-growth region over the forecast period.
Negative Pressure Wound Therapy Systems Market Regional Commentary
North America
North America accounted for 42% of the global Negative Pressure Wound Therapy Systems market revenue in 2025. The United States dominates the region on the strength of a high diabetes and chronic wound burden, extensive wound care networks, strong adoption of single-use and closed-incision NPWT, and the presence of leading manufacturers, while Canada advances through public healthcare wound programs and Mexico expands wound care capacity within its growing healthcare sector.
Europe
Europe represents the second-largest regional market, led by Germany, the United Kingdom, and France. Growth is supported by a high burden of diabetes and chronic wounds, established wound care systems, and the presence of major manufacturers such as Smith & Nephew, Molnlycke, Convatec, and Paul Hartmann, while the European Medical Device Regulation raises evidence requirements for NPWT devices.
Asia-Pacific
Asia-Pacific is the fastest-growing region, propelled by large aging populations, a rapidly rising diabetes prevalence, and expanding healthcare and surgical access across China, Japan, India, South Korea, and Australia. Growing awareness of advanced wound care and surgical site infection prevention is broadening adoption of conventional and single-use NPWT.
Rest of World
The Rest of World region, spanning the Middle East, Africa, and South America, is an emerging growth frontier. A rising diabetes and chronic wound burden, gradual improvements in wound care infrastructure, and increasing availability of NPWT devices are expanding access, while investment in healthcare capacity supports the broader adoption of negative pressure wound therapy.
Negative Pressure Wound Therapy Systems Market Competitive Landscape
The Negative Pressure Wound Therapy Systems market is classified as Consolidated. A small group of manufacturers controls the majority of revenue, led by Solventum, whose V.A.C. therapy franchise is the market benchmark, and Smith & Nephew through its PICO and RENASYS systems, followed by Convatec, Cardinal Health, and Molnlycke, with specialized and regional providers competing in single-use and cost-focused segments.
The competitive landscape can be evaluated across the following dimensions:
- Market concentration: Consolidated, with revenue concentrated among a few leaders and high barriers from installed base, proprietary consumables, and clinical evidence.
- Leading players: Solventum and Smith & Nephew anchor the market, with Convatec, Cardinal Health, and Molnlycke as key competitors.
- Geographic reach: Leaders operate global commercial and clinical networks, with strong positions across North America, Europe, and Asia-Pacific.
- Product portfolio strength: Top players offer portfolios spanning conventional, instillation, single-use, and closed-incision NPWT and associated consumables.
- Pipeline strength: Active development in single-use and closed-incision NPWT, instillation therapy, connectivity, and improved dressings.
- Strategic partnerships: Collaborations with wound care and surgical programs and distributors extend reach across hospital and home settings.
- M&A activity: Consolidation continues across wound care, and the spin-off of Solventum from 3M reshaped the NPWT landscape.
- Manufacturing capabilities: Scale manufacturing of devices, foam, dressings, and canisters is a key competitive moat and driver of recurring revenue.
- Innovation focus: Single-use and closed-incision NPWT, instillation therapy, portability and connectivity, and disposable and home-focused designs.
Negative Pressure Wound Therapy Systems Market Recent Developmental Activities
- In 2024, Solventum Corporation was established as an independent company through the spin-off of 3M's health care business, including the KCI V.A.C. negative pressure wound therapy franchise. Strategic significance: Creates a focused health care company with the market-leading NPWT portfolio, including V.A.C., Prevena, and instillation therapy.
- In 2023 and 2024, Smith & Nephew plc advanced its PICO single-use NPWT and RENASYS conventional NPWT systems for a range of wound and incision applications. Strategic significance: Reinforces Smith & Nephew's leadership across single-use and conventional NPWT and closed-incision management.
- In 2023 and 2024, single-use NPWT for closed surgical incisions gained further clinical evidence, with systematic reviews and meta-analyses demonstrating reduced surgical site infections compared with conventional dressings. Strategic significance: Strengthens the evidence base for prophylactic closed-incision NPWT and supports adoption and reimbursement.
- In 2023 and 2024, Convatec Group PLC advanced its Avelle single-use NPWT system for chronic and acute wounds. Strategic significance: Expands Convatec's presence in single-use NPWT and broadens its advanced wound care portfolio.
- In 2023 and 2024, Solventum advanced its Prevena closed-incision NPWT and V.A.C. VeraFlo instillation therapy for surgical site infection prevention and complex infected wounds. Strategic significance: Reinforces leadership in closed-incision and instillation NPWT, key growth applications.
- In 2023 and 2024, Molnlycke Health Care AB advanced its Avance NPWT and single-use offerings. Strategic significance: Strengthens Molnlycke's position in NPWT, complementing its advanced dressing portfolio.
- In 2023 and 2024, Cardinal Health, Inc. advanced its NPWT portfolio for hospital and home wound care. Strategic significance: Maintains competitive breadth in NPWT across care settings.
- In 2024 and 2025, manufacturers expanDry Eye Disease portable and single-use NPWT for outpatient and home use. Strategic significance: Extends NPWT beyond the hospital and supports the shift to home-based wound care.
- In 2024 and 2025, reimbursement policies and documentation requirements for NPWT durable medical equipment, including competitive bidding in some systems, continued to shape access. Strategic significance: Influences adoption and pricing, particularly for home NPWT.
- In 2023 and 2024, DeRoyal Industries, Talley Group, and other providers advanced conventional and single-use NPWT devices. Strategic significance: Broadens the availability of NPWT and supports competition across segments.
- In 2024 and 2025, manufacturers advanced connected and quieter NPWT devices with improved dressings and canisters. Strategic significance: Improves usability and patient experience and differentiates competing systems.
- In 2024 and 2025, the transition to the European Medical Device Regulation continued to shape NPWT device compliance and evidence requirements. Strategic significance: Raises clinical evidence standards and favors established manufacturers with resources to comply.
Negative Pressure Wound Therapy Systems Market Segmentation
- Negative Pressure Wound Therapy Systems Market by Product Type
- Conventional NPWT Devices
- Single-Use NPWT Devices
- Negative Pressure Wound Therapy Systems Market by Wound Type
- Diabetic Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Surgical and Traumatic Wounds
- Burns
- Others
- Negative Pressure Wound Therapy Systems Market by End-User
- Hospitals
- Specialty and Ambulatory Clinics
- Home Care Settings
- Others
Negative Pressure Wound Therapy Systems Market by Geography
- North America Negative Pressure Wound Therapy Systems Market
- United States Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- Canada Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- Mexico Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- Europe Negative Pressure Wound Therapy Systems Market
- Germany Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- United Kingdom Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- France Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- Italy Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- Spain Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- Rest of Europe Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- Asia-Pacific Negative Pressure Wound Therapy Systems Market
- China Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- Japan Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- India Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- Australia Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- South Korea Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- Rest of Asia-Pacific Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- Rest of the World (RoW) Negative Pressure Wound Therapy Systems Market
- Middle East Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- Africa Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
- South America Negative Pressure Wound Therapy Systems Market Size in USD million (2023-2034)
Negative Pressure Wound Therapy Systems Market Recent Industry Trends and Milestones (2023-2026):
|
Category |
Key Developments |
|
Negative Pressure Wound Therapy Systems Market Product Approval |
Manufacturers obtained FDA clearances and CE marking for conventional, single-use, closed-incision, and instillation NPWT devices (2023-2025); single-use NPWT for closed surgical incisions gained clinical evidence supporting surgical site infection reduction; the European Medical Device Regulation reshaped compliance requirements for NPWT; portable and disposable devices received clearances supporting home use. |
|
Negative Pressure Wound Therapy Systems Market Product Expansion |
Solventum advanced V.A.C., Prevena closed-incision, and V.A.C. VeraFlo instillation therapy; Smith & Nephew advanced PICO single-use and RENASYS conventional NPWT; Convatec advanced Avelle single-use NPWT; Molnlycke advanced Avance NPWT; Cardinal Health, DeRoyal, and Talley advanced conventional and single-use devices; manufacturers expanded portable and home-focused NPWT. |
|
Negative Pressure Wound Therapy Systems Market Product Investment |
Solventum was established through the 3M health care spin-off with the market-leading NPWT franchise (2024); manufacturers invested in single-use, closed-incision, instillation, and connected NPWT; capital continued to flow toward portable and home-focused devices and disposable technology; investment supported the expansion of surgical site infection prevention applications. |
|
Company Strategy |
Solventum Corporation: Market-leading V.A.C., Prevena, and instillation NPWT. Smith & Nephew plc: PICO single-use and RENASYS conventional NPWT and closed-incision management. Convatec Group PLC: Avelle single-use NPWT and advanced wound care. Molnlycke Health Care AB and Cardinal Health, Inc.: Conventional and single-use NPWT. DeRoyal, Talley Group, Paul Hartmann, and Genadyne: Conventional and single-use devices across settings. |
|
Negative Pressure Wound Therapy Systems Market Emerging Technologies |
Single-use and disposable NPWT extending therapy to smaller wounds and home settings; closed-incision NPWT for surgical site infection prevention; instillation NPWT combining negative pressure with topical wound irrigation for infected and complex wounds; portable, quieter, and connected devices with improved dressings and canisters; home-focused NPWT supporting the shift to outpatient care; evidence-based prophylactic use in high-risk surgical patients. |
Negative Pressure Wound Therapy Systems Market Startup Funding and Investment Trends
Investment in the NPWT ecosystem has concentrated on portable and disposable devices and advanced wound care technologies. The following companies illustrate recent activity and technology focus.
|
Company |
Total Funding |
Funding Stage |
Main Product |
Core Technology |
|
Cork Medical, LLC |
Private and venture funding |
Privately held |
NANOVA Portable NPWT |
Portable negative pressure wound therapy |
|
Sanara MedTech Inc. |
Public and venture funding |
Public / growth-stage |
Advanced wound and NPWT portfolio |
Advanced wound care and soft-tissue repair |
|
Request for unlocking the report of the @ Negative Pressure Wound Therapy Systems Market Insights
| ||||
Cork Medical is scaling its NANOVA portable negative pressure wound therapy system for hospital and home use, while Sanara MedTech advances an advanced wound care and soft-tissue repair portfolio that includes negative pressure and regenerative solutions. Additional capital continues to flow toward portable and disposable NPWT, closed-incision and instillation approaches, and connected wound care, reflecting conviction that portability, surgical site infection prevention, and home-based therapy are the next sources of competitive advantage. Collectively, these efforts signal sustained investment in expanding access to NPWT, improving outcomes for complex and surgical wounds, and extending therapy across care settings.
Key Takeaways from the Negative Pressure Wound Therapy Systems Market Report Study
- Market size analysis for the current negative pressure wound therapy systems market size (2025), and market forecast for 9 years (2026 to 2034).
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that have happened over the last 3 years.
- Key companies dominating the global negative pressure wound therapy systems market.
- Various opportunities available for competitors in the negative pressure wound therapy systems market space.
- What are the top-performing segments in 2025? How will these segments perform in 2034?
- Which are the top-performing regions and countries in the current negative pressure wound therapy systems market scenario?
- Which are the regions and countries where companies should concentrate their opportunities for negative pressure wound therapy systems market growth in the future?
Target audience who can benefit from this negative pressure wound therapy systems market report study
- Negative Pressure Wound Therapy Systems product providers
- Research organizations and consulting companies
- Negative Pressure Wound Therapy Systems-related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and traders dealing in negative pressure wound therapy systems
- Various end-users who want to know more about the negative pressure wound therapy systems market and the latest technological developments in the negative pressure wound therapy systems market.





